General Information of the Compound
Compound ID
CP0535111
Compound Name
4-(Benzylamino)quinazoline deriv. 31
    Show/Hide
Structure
Formula
C16H15N3O
Molecular Weight
265.316
Canonical SMILES
COc1ccc2ncnc(NCc3ccccc3)c2c1
    Show/Hide
InChI
InChI=1S/C16H15N3O/c1-20-13-7-8-15-14(9-13)16(19-11-18-15)17-10-12-5-3-2-4-6-12/h2-9,11H,10H2,1H3,(H,17,18,19)
    Show/Hide
InChIKey
FNDTUROJPCNKSJ-UHFFFAOYSA-N
Physicochemical Property
logP
3.2505
Rotatable Bonds
4
Heavy Atom Count
20
Polar Areas
47.04
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5328029
SID: 15247371
ChEMBL ID
CHEMBL332938
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS